Stentys' Series B - II Round

Stentys raised a round of funding on June 22, 2009. Investors include Omnes Capital.

Stentys is developing and commercializing innovative solutions for the treatment of patients with acute myocardial infarction (AMI, or heart attack) and complex coronary artery disease. Stentys' Self-…

Articles about Stentys' Series B - II Round: